Dooseop Kim

Statistics

Publications

Citations

H-Index

Active since

1985

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Pittsburgh

Korea Research Institute of Chemical Technology

Korea Advanced Institute of Science and Technology

Dooseop Kim is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and molecular pharmacology.

Publications per year

1985–2024

Publications

(2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Dooseop Kim, Liping Wang, Maria Beconi et al. · Journal of Medicinal Chemistry · 2004 · 817 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes

George R. Lankas, Barbara Leiting, Ranabir Sinha Roy et al. · Diabetes · 2005 · 491 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Translocation of radical sites by intramolecular 1,5-hydrogen atom transfer

Dennis P. Curran, Dooseop Kim, Hong Tao. Liu · Journal of the American Chemical Society · 1988 · 198 citations

Natural Sciences, Biochemistry, Chemistry +6

Potent, orally absorbed glucagon receptor antagonists

Stephen E. de Laszlo, Candice Hacker, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 169 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Dooseop Kim, Liping Wang, Jeffrey J. Hale et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 149 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

1–5 of 28